Treatment of neuroblastoma meningeal carcinomatosis with intrathecal application of α-emitting atomic nanogenerators targeting disialo-ganglioside GD2

Clinical Cancer Research

Volumn 10, Issue 20, 2004, Pages 6985-6992

  Miederer, Matthias ^a   McDevitt, Michael R ^a   Borchardt, Paul ^a   Bergman, Ira ^b   Kramer, Kim ^a   Cheung, Nai Kong V ^a   Scheinberg, David A ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1,4,7,10 TETRAAZACYCLODODECANE 1,4,7,10 TETRAACETIC ACID; ACTINIUM; ACTINIUM 225; ANTIBODY CONJUGATE; GANGLIOSIDE GD2; IMMUNOGLOBULIN G ANTIBODY; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY 3F8; UNCLASSIFIED DRUG;

ALPHA RADIATION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY LABELING; APOPTOSIS; ARTICLE; ATOMIC PARTICLE; BLOOD; CANCER MODEL; CANCER SURVIVAL; CARCINOMATOUS MENINGITIS; CONTROLLED STUDY; DRUG CYTOTOXICITY; DRUG DISTRIBUTION; DRUG EFFECT; DRUG EFFICACY; DRUG METABOLISM; DRUG PURITY; DRUG STERILITY; IC 50; IMMUNOREACTIVITY; KIDNEY; MONKEY; NEUROBLASTOMA; NEUROECTODERM TUMOR; NONHUMAN; NUDE MOUSE; PRIORITY JOURNAL; RAT; SMALL INTESTINE; SURVIVAL TIME; TUMOR XENOGRAFT;

ACTINIUM; ANIMALS; ANTIBODIES, MONOCLONAL; CARCINOMA; GANGLIOSIDES; HAPLORHINI; HUMANS; IMMUNOCONJUGATES; IMMUNOGLOBULIN G; INJECTIONS, SPINAL; MENINGEAL NEOPLASMS; MICE; NEUROBLASTOMA; RATS; RATS, NUDE; SURVIVAL ANALYSIS; TISSUE DISTRIBUTION; TRANSPLANTATION, HETEROLOGOUS;

EID: 6044248953     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: 10.1158/1078-0432.CCR-04-0859     Document Type: Article

References (21)

1. Cheung NK, Kushner BH, LaQuaglia M, et al. J N7: a novel multi-modality therapy of high risk neuroblastoma (NB) in children diagnosed over 1 year of age. Med Pediatr Oncol 2001;36:227-30.
2. Cheung NK, Kushner BH, Yeh SD, Larson SM. 3F8 monoclonal antibody treatment of patients with stage 4 neuroblastoma: a phase II study. Int J Oncol 1998;12:1299-306.
3. I-monoclonal antibody targeting disialoganglioside in non-human primates. J Neuro-Oncol 1997;35:101-11.
4. Arbit E, Cheung NK, Yeh SD, et al. Quantitative studies of monoclonal antibody targeting to disialoganglioside GD2 in human brain tumors. Eur J Nucl Med 1995;22:419-26.
5. Miraldi FD, Nelson AD, Kraly C, et al. Diagnostic imaging of human neuroblastoma with radiolabeled antibody. Radiology 1986;161:413-8.
6. Cheung NK, Kushner BH, Kramer K. Monoclonal antibody-based therapy of neuroblastoma. In: Coppes M, Arceci R, editors. Hematology/Oncology Clinics of North America, vol. 15. Philadelphia, PA: W. B. Saunders Company; 2001. p. 853-66.
7. Zalutsky MR, McLendon RE, Garg PK, et al. Radioimmunotherapy of neoplastic meningitis in rats using an alpha-particle-emitting immunoconjugate. Cancer Res 1994;54:4719-25.
8. McDevitt MR, Ma D, Lai LT, et al. Tumor therapy with targeted atomic nanogenerators. Science (Wash DC) 2001;294:1537-40.
9. Cheung NK, Saarinen UM, Neely JE, et al. Monoclonal antibodies to a glycolipid antigen on human neuroblastoma cells. Cancer Res 1985;45:2642-9.
10. Cheung NK, Canete A, Cheung IY, Ye JN, Liu C. Disialoganglioside GD2 anti-idiotypic monoclonal antibodies. Int J Cancer 1993;54:499-505.
11. Ac radioimmunopharmaceuticals. Appl Radial Isot 2002;57:841-7.
12. Nikula TK, McDevitt MR, Finn RD, et al. Alpha-emitting bismuth cyclohexylbenzyl DTPA constructs of recombinant humanized anti-CD33 antibodies: pharmacokinetics, bioactivity, toxicity and chemistry. J Nucl Med 1999;40:166-76.
13. Bergman I, Ahdab-Barmada M, Kemp SS, Griffin JA, Cheung NK. A rat model of leptomeningeal human neoplastic xenografts. J Neuro-Oncol 1997;34:221-31.
14. Bergman I, Pohl CR, Venkataramanan R, et al. Intrathecal administration of an anti-ganglioside antibody results in specific accumulation within meningeal neoplastic xenografts in nude rats. J Immunother 1999;22:114-23.
15. Miederer M, McDevitt MR, Sgouros G, et al. Pharmacokinetics, dosimetry and toxicity of the targetable atomic generator, Actinium-225-HuM195 in non-human primates. J Nucl Med 2004;45:129-37.
16. Cheung NK, Landmeier B, Neely J, et al. Complete tumor ablation with iodine 131-radiolabeled disialoganglioside GD2-specific monoclonal antibody against human neuroblastoma xenografted in nude mice. J Natl Cancer Inst (Bethesda) 1986;77:739-45.
17. F-3F8: clinical validation of imaging studies and therapeutic applications. Prog Clin Biol Res 1991;366:409-15.
18. Y-labeled CO17-1A Fab' fragments in a human colonic cancer model. Cancer Res 1999;59:2635-43.
19. Bi] J591) for radioimmunotherapy of prostate cancer. Cancer Res 2000;60:6095-100.
20. Macklis RM, Lin JY, Beresford B, et al. Cellular kinetics, dosimetry, and radiobiology of alpha-particle radioimmunotherapy: induction of apoptosis. Radiat Res 1992;130:220-6.
21. Bergman I, Burckart GJ, Pohl CR, et al. Pharmacokinetics of IgG and IgM anti-ganglioside antibodies in rats and monkeys after intrathecal administration. J Pharmacol Exp Ther 1998;284:111-5.